Delving into the Latest Updates on The Asan Foundation with Synapse

Phase 2, Open-label, Non-randomized, Single Center Study to Explore Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Subjects With Inflammatory Bowel Disease.

Diagnostic validity of [18F]FSPG for assessing disease activity will be assessed in subjects with inflammatory bowel disease.

开始日期2018-08-14

申办/合作机构

The Asan Foundation

NCT03112096 / Completed临床1期IIT

A Phase I [18F]THK-5351 Positron Emission Computed Tomography Study of Biodistribution, Pharmacokinetics and Safety in Cognitively Healthy Subjects and Patients With Alzheimer's Disease

This is a study to evaluate biodistribution, pharmacokinetics and safety of [18F]THK-5351 positron emission computed tomography in Cognitively Healthy Subjects and Patients with Alzheimer's Disease.

开始日期2017-05-17

申办/合作机构

The Asan Foundation

NCT02864810 / Completed临床1期IIT

A Phase 1, Open-label, Non-randomized, Single Center Study to Assess Safety, Pharmacokinetics, Biodistribution, Internal Radiation Dosimetry and Diagnostic Performance of [18F]GP1 Positron Emission Tomography in Subjects With Venous or Arterial Thromboembolism

[18F]GP1 targets platelet GPIIb/IIIa receptor in thrombus. [18F]GP1 PET/CT imaging will noninvasively assess thrombus in whole body with good sensitivity with information of thrombus. Safety, pharmacokinetics, biodistribution, internal radiation dosimetry and diagnostic performance of [18F]GP1 will be assessed in all subjects.

开始日期2016-08-04

申办/合作机构

The Asan Foundation

100 项与 The Asan Foundation 相关的临床结果

登录后查看更多信息

0 项与 The Asan Foundation 相关的专利（医药）

登录后查看更多信息

100 项与 The Asan Foundation 相关的药物交易

登录后查看更多信息

100 项与 The Asan Foundation 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年11月22日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

药物发现

3

2

其他

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

WO2024049280 ( SOD1 )专利挖掘	呼吸系统疾病更多	药物发现
KR1020220014818 ( V-set domain containing )专利挖掘	胃肠道肿瘤更多	药物发现
KR1020220002098 ( LGALS3BP )专利挖掘	肿瘤更多	药物发现
BAY-94-9392 ( SLC7A11 )	克罗恩病更多	无进展
[18F]THK-5351 ( TAU )	阿尔茨海默症更多	无进展